Shalini Sharp Joins BeiGene’s Board Amid Global Expansion
Slice of Healthcare Team
Oct 03, 2024
Key Highlights
- Shalini Sharp appointed to BeiGene’s Board of Directors and Audit Committee.
- Brings extensive financial expertise and experience in global pharmaceutical leadership.
- Appointment comes during BeiGene's pivotal global expansion and transformative growth.
- Sharp has previously held leadership roles at Ultragenyx, Neurocrine Biosciences, and more.
Source: Business Wire
Notable Quotes
“ The Board is looking forward to collaborating with Shalini, whose extensive experience in leading innovative global pharmaceutical companies will be invaluable as we enter new markets, advance our pipeline of groundbreaking cancer therapies, and embark on a transformative growth phase. ”
John V. Oyler, Co-Founder, Chairman, and CEO at BeiGene
“ BeiGene’s commitment to innovation and differentiated mission to lower barriers to access around the world resonate deeply with me, and I’m excited to work with the Board to impact even more patients’ lives. ”
Shalini Sharp, Board Member at BeiGene
